FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103236867> ?p ?o ?g. }

• W2103236867 endingPage "vii72" @default.
• W2103236867 startingPage "vii68" @default.
• W2103236867 abstract "Biliary tract cancers are uncommon tumors with a poor prognosis and most patients present with invasive and inoperable disease at diagnosis. Chemotherapy represents a palliative treatment, with poor response rates and a median survival of less than 6 months. Oxaliplatin and gemcitabine have shown an interesting activity as single agents in this group of patients.We carried out a multicenter phase II study to evaluate the efficacy and safety of combined oxaliplatin and gemcitabine in locally advanced and metastatic biliary tract carcinoma. The schedule of chemotherapy included oxaliplatin 100 mg/m(2) on day 1 and gemcitabine 1000 mg/m(2) on days 1 and 8, every 21 days.All the 24 patients were evaluable for response and toxicity. According to RECIST criteria we observed one complete response and 11 partial responses for an overall response rate of 50%. Overall survival for all the patients on study was 12 months (range 2-30). According to WHO criteria, three patients (12.5%) suffered grade 3 neutropenia and three patients (12.5%) grade 3 thrombocytopenia. Only two patients (8%) suffered grade 3 neuropathy.Oxaliplatin and gemcitabine chemotherapy seems to be effective with a favorable safety profile in first-line chemotherapy of advanced biliary tract cancers." @default.
• W2103236867 created "2016-06-24" @default.
• W2103236867 creator A5011753332 @default.
• W2103236867 creator A5017866134 @default.
• W2103236867 creator A5040067747 @default.
• W2103236867 creator A5048135852 @default.
• W2103236867 creator A5050289046 @default.
• W2103236867 creator A5055919267 @default.
• W2103236867 creator A5056329331 @default.
• W2103236867 creator A5068175716 @default.
• W2103236867 creator A5074505184 @default.
• W2103236867 creator A5075338390 @default.
• W2103236867 creator A5081037032 @default.
• W2103236867 date "2006-06-01" @default.
• W2103236867 modified "2023-10-16" @default.
• W2103236867 title "Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers" @default.
• W2103236867 cites W138827541 @default.
• W2103236867 cites W1908187732 @default.
• W2103236867 cites W1911108481 @default.
• W2103236867 cites W1990738112 @default.
• W2103236867 cites W2016338128 @default.
• W2103236867 cites W2041119913 @default.
• W2103236867 cites W2065134430 @default.
• W2103236867 cites W2065889106 @default.
• W2103236867 cites W2073152865 @default.
• W2103236867 cites W2076668534 @default.
• W2103236867 cites W2082598176 @default.
• W2103236867 cites W2089604747 @default.
• W2103236867 cites W2093388808 @default.
• W2103236867 cites W2096888043 @default.
• W2103236867 cites W2099386389 @default.
• W2103236867 cites W2103529483 @default.
• W2103236867 cites W2117050193 @default.
• W2103236867 cites W2128719076 @default.
• W2103236867 cites W2128889451 @default.
• W2103236867 cites W2132865716 @default.
• W2103236867 cites W2139248078 @default.
• W2103236867 cites W2139947970 @default.
• W2103236867 cites W2151322055 @default.
• W2103236867 cites W2188928518 @default.
• W2103236867 cites W2332605220 @default.
• W2103236867 cites W4293241248 @default.
• W2103236867 doi "https://doi.org/10.1093/annonc/mdl955" @default.
• W2103236867 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16760298" @default.
• W2103236867 hasPublicationYear "2006" @default.
• W2103236867 type Work @default.
• W2103236867 sameAs 2103236867 @default.
• W2103236867 citedByCount "50" @default.
• W2103236867 countsByYear W21032368672012 @default.
• W2103236867 countsByYear W21032368672013 @default.
• W2103236867 countsByYear W21032368672014 @default.
• W2103236867 countsByYear W21032368672015 @default.
• W2103236867 countsByYear W21032368672016 @default.
• W2103236867 countsByYear W21032368672017 @default.
• W2103236867 countsByYear W21032368672018 @default.
• W2103236867 countsByYear W21032368672019 @default.
• W2103236867 countsByYear W21032368672020 @default.
• W2103236867 countsByYear W21032368672021 @default.
• W2103236867 crossrefType "journal-article" @default.
• W2103236867 hasAuthorship W2103236867A5011753332 @default.
• W2103236867 hasAuthorship W2103236867A5017866134 @default.
• W2103236867 hasAuthorship W2103236867A5040067747 @default.
• W2103236867 hasAuthorship W2103236867A5048135852 @default.
• W2103236867 hasAuthorship W2103236867A5050289046 @default.
• W2103236867 hasAuthorship W2103236867A5055919267 @default.
• W2103236867 hasAuthorship W2103236867A5056329331 @default.
• W2103236867 hasAuthorship W2103236867A5068175716 @default.
• W2103236867 hasAuthorship W2103236867A5074505184 @default.
• W2103236867 hasAuthorship W2103236867A5075338390 @default.
• W2103236867 hasAuthorship W2103236867A5081037032 @default.
• W2103236867 hasBestOaLocation W21032368671 @default.
• W2103236867 hasConcept C121608353 @default.
• W2103236867 hasConcept C126322002 @default.
• W2103236867 hasConcept C141071460 @default.
• W2103236867 hasConcept C143998085 @default.
• W2103236867 hasConcept C2775982439 @default.
• W2103236867 hasConcept C2776694085 @default.
• W2103236867 hasConcept C2777063308 @default.
• W2103236867 hasConcept C2780258809 @default.
• W2103236867 hasConcept C2780962732 @default.
• W2103236867 hasConcept C31760486 @default.
• W2103236867 hasConcept C526805850 @default.
• W2103236867 hasConcept C71924100 @default.
• W2103236867 hasConcept C90924648 @default.
• W2103236867 hasConceptScore W2103236867C121608353 @default.
• W2103236867 hasConceptScore W2103236867C126322002 @default.
• W2103236867 hasConceptScore W2103236867C141071460 @default.
• W2103236867 hasConceptScore W2103236867C143998085 @default.
• W2103236867 hasConceptScore W2103236867C2775982439 @default.
• W2103236867 hasConceptScore W2103236867C2776694085 @default.
• W2103236867 hasConceptScore W2103236867C2777063308 @default.
• W2103236867 hasConceptScore W2103236867C2780258809 @default.
• W2103236867 hasConceptScore W2103236867C2780962732 @default.
• W2103236867 hasConceptScore W2103236867C31760486 @default.
• W2103236867 hasConceptScore W2103236867C526805850 @default.
• W2103236867 hasConceptScore W2103236867C71924100 @default.
• W2103236867 hasConceptScore W2103236867C90924648 @default.
• W2103236867 hasLocation W21032368671 @default.

• next